| scholarly article | Q13442814 |
| P2093 | author name string | Xin Wang | |
| Jinming Yu | |||
| Jie Lu | |||
| Jianbo Zhang | |||
| Dianbin Mu | |||
| Feifei Teng | |||
| P2860 | cites work | Risk factors for tumor recurrence in patients with early-stage (stage I and II) non-small cell lung cancer: patient selection criteria for adjuvant chemotherapy according to the seventh edition TNM classification. | Q53244493 |
| PLK4 is a determinant of temozolomide sensitivity through phosphorylation of IKBKE in glioblastoma | Q90356457 | ||
| TANK-binding kinase 1 is a mediator of platelet-induced EMT in mammary carcinoma cells | Q92626368 | ||
| IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases | Q22010432 | ||
| NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase | Q22010870 | ||
| SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK | Q24310727 | ||
| Akt1 regulates pathological angiogenesis, vascular maturation and permeability in vivo | Q24648140 | ||
| Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling | Q24679268 | ||
| Molecular basis of Tank-binding kinase 1 activation by transautophosphorylation | Q27679261 | ||
| Crystal structure and mechanism of activation of TANK-binding kinase 1 | Q27684100 | ||
| Cancer statistics, 2013 | Q27860762 | ||
| NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation | Q28141521 | ||
| Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer | Q33988009 | ||
| IKBKE protein activates Akt independent of phosphatidylinositol 3-kinase/PDK1/mTORC2 and the pleckstrin homology domain to sustain malignant transformation | Q34215333 | ||
| RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival | Q34571216 | ||
| Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. | Q34682122 | ||
| Silencing of the IKKε gene by siRNA inhibits invasiveness and growth of breast cancer cells | Q34989052 | ||
| Regulation of T-cell activation and migration by the kinase TBK1 during neuroinflammation | Q34999011 | ||
| Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets | Q36116625 | ||
| IκB Kinase ε expression in pancreatic ductal adenocarcinoma | Q36280308 | ||
| Identification of TBK1 and IKKε, the non-canonical IκB kinases, as crucial pro-survival factors in HTLV-1-transformed T lymphocytes | Q36984362 | ||
| Signaling to NF-kappaB by Toll-like receptors | Q37009320 | ||
| Dissection of TBK1 signaling via phosphoproteomics in lung cancer cells | Q37049369 | ||
| Are the IKKs and IKK-related kinases TBK1 and IKK-epsilon similarly activated? | Q37114307 | ||
| Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer | Q37257188 | ||
| Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer. | Q37477973 | ||
| Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up | Q37489156 | ||
| Selective TBK1/IKKi dual inhibitors with anticancer potency | Q37626577 | ||
| IKKε and TBK1 expression in gastric cancer | Q37725411 | ||
| IκB kinase ε (IKKε): a therapeutic target in inflammation and cancer | Q38075370 | ||
| Personalized treatment of early-stage non-small-cell lung cancer: the challenging role of EGFR inhibitors | Q38400481 | ||
| IKBKE is over-expressed in glioma and contributes to resistance of glioma cells to apoptosis via activating NF-κB. | Q38413034 | ||
| Inhibition of KRAS-driven tumorigenicity by interruption of an autocrine cytokine circuit. | Q38665092 | ||
| mTOR Signaling in Growth, Metabolism, and Disease. | Q38747508 | ||
| IKKε-mediated tumorigenesis requires K63-linked polyubiquitination by a cIAP1/cIAP2/TRAF2 E3 ubiquitin ligase complex. | Q39186578 | ||
| Silencing of IKKε using siRNA inhibits proliferation and invasion of glioma cells in vitro and in vivo | Q39354829 | ||
| IKBKE regulates cell proliferation and epithelial-mesenchymal transition of human malignant glioma via the Hippo pathway | Q41472551 | ||
| Inactivation of the enzyme GSK3α by the kinase IKKi promotes AKT-mTOR signaling pathway that mediates interleukin-1-induced Th17 cell maintenance | Q41772814 | ||
| Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers | Q42458122 | ||
| IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer | Q42746137 | ||
| The transient and constitutive inflammatory signaling in tumorigenesis | Q42856220 | ||
| Inducible IkappaB kinase/IkappaB kinase epsilon expression is induced by CK2 and promotes aberrant nuclear factor-kappaB activation in breast cancer cells | Q46853168 | ||
| The IKK-related kinase TBK1 activates mTORC1 directly in response to growth factors and innate immune agonists | Q47576629 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 6593-6602 | |
| P577 | publication date | 2019-07-15 | |
| P1433 | published in | Cancer Management and Research | Q5031417 |
| P1476 | title | Expression and prognostic role of IKBKE and TBK1 in stage I non-small cell lung cancer | |
| P478 | volume | 11 |
Search more.